primer combinations were evaluated. The most sensitive PCR was used to demonstrate that 23 papillomavirus DNA can be detected on non-lesional skin of dogs. 24 that can induce benign as well as malignant neoplasias in the skin and mucous membranes 26 (24). PV DNA has also been detected on the skin of clinically healthy humans and certain 27 animal species (1-4, 6, 7, 16, 17). Likewise, clinically healthy dogs have been shown to carry 28 antibodies against PVs (14) . Nevertheless, previous attempts to detect PV DNA on the skin of 29 healthy dogs have been unsuccessful (3). 30
To address this issue, eight PCR assays with previously published primer combinations 31 targeting either the L1 or the E1 open reading frame were assessed (Table 1 and references 32 therein). These PCR assays were evaluated for their ability to detect the DNA of the seven 33 classified canine PVs (CPVs) (5, 9, 12, 20-22). Furthermore, the sensitivity and specificity of 34 each assay was determined in the same context. 35
Eight different published primarily broad range primer pairs were tested (Table 1) The test population of 95 dogs was recruited from patients of the small animal hospital of the 84 University of Zurich displaying no clinical signs of any described kind of papillomatosis. To 85 obtain skin samples from these dogs, fresh cytobrush sticks were used in the oral cavity and 86 on the interdigital skin. The cytobrushes were rubbed six turns on the target regions and 87 afterwards placed in an 1.5ml Eppendorf tube containing 1ml of sterile 0.9% NaCl. The 88 samples were kept at 4°C for no longer than 24 hours and were then stored below -18°C until 89 extraction. Before DNA extraction, each cytobrush was flushed repeatedly with the 0.9% 90 NaCl it had been kept in. To concentrate all cells and cell debris at the bottom of the tube, 91 tubes (still containing the cytobrush tip) were centrifuge at 15000 g for 10 min. The cytobrush 92 tip and the 0.9% NaCl were then carefully removed except for about the last 25 µl. DNA was 93 afterwards extracted using the DNeasy extraction kit (Qiagen, Hombrechtikon, Switzerland) 94 following the manufacturer's instructions, eluting DNA finally in 100µl sterile water. 95
Extraction and handling of this sample DNA was performed entirely separated from any other 96 PV research. 97
All sampling was carried out with respect to the Swiss regulations about research on animals. 98
As shown in Table 1 , PCR with the L1 primer combination canPVf/FAP64 detected five of 99 the seven CPVs at a target concentration of 10 2 molecules or less, while CPV2-and CPV7-100 DNA was still detected at a target concentration of 10 4 molecules. Assays with E1 primers 101 reason may be that some primers aligned well with certain CPV sequences but poorly with 104 others (S2). RCA is a frequently used alternative method to amplify PV DNA (18). 105
Evaluation of its sensitivity revealed that it required a minimum of 10 6 molecules to 106 successfully amplify PV DNA (data not shown), thus RCA was not favoured for the detection 107 of CPV DNA on the healthy skin. 108
Based on the primer evaluation, the canPVf/FAP64 PCR was chosen to assess cytobrush 109 samples from the skin and oral mucosa of 95 asymptomatic dogs. A dogGAPDH PCR assay 110 (requiring 10 4 molecules for a positive detection) was used as an amplification control. This 111 PCR provided a positive signal with all samples taken from the oral cavity and with 81% of 112 samples taken from the interdigital skin (S3). CPV DNA was detected in more than 50% of 113 the dogs (S3), i.e. in 23% of oral samples whose complementary skin samples were negative; 114 14% of skin samples (oral samples negative); 15% of samples from both locations. In 48% of 115 the dogs PV DNA was detected neither in skin nor in oral samples. Interestingly, in two cases 116 putative PV DNA was amplified from the skin with canPVf/FAP64 although the dogGAPDH 117 PCR assay had been negative. A number of randomly selected products arising from 118 canPVf/FAP64-mediated PCR were sequenced. The sequences obtained from two oral and 119 three skin samples were clearly identified as CPV1. In contrast, the amplification products of 120 five oral and two skin samples did not yield meaningful sequencing results, most probably 121 due to the presence of DNA from more than one PV type in the sample. 122
In conclusion, the sensitivity and specificity for each of eight previously described PV primer 123 pairs was assessed in the context of PCR for the detection of CPV DNA. Application of a 124 broad-range, high sensitive primer pair suggests that the clinically unaffected skin and oral 125 cavity of dogs might be a reservoir for canine papillomaviruses. 
